Debrisoquine oxidation phenotype and susceptibility to lung cancer
Br J Clin Pharmacol
.
1990 Oct;30(4):653-6.
doi: 10.1111/j.1365-2125.1990.tb03832.x.
Authors
A R Boobis
,
D S Davies
PMID:
2291880
PMCID:
PMC1368264
DOI:
10.1111/j.1365-2125.1990.tb03832.x
No abstract available
Publication types
Comment
Letter
MeSH terms
Debrisoquin / metabolism*
Debrisoquin / urine
Disease Susceptibility
Gas Chromatography-Mass Spectrometry
Humans
Lung Neoplasms / genetics*
Lung Neoplasms / metabolism
Oxidation-Reduction
Phenotype*
Substances
Debrisoquin